15 November 2024
Guardian Metal Resources plc ("Guardian Metal" or the "Company")
Issue of Equity for Settlement of Fees
Guardian Metal Resources plc (LON:GMET/OTCQB:GMTLF), a strategic mineral exploration and development company focused on Nevada, US, announces an issue of shares in lieu of cash for settlement of fees.
Settlement of Fees - Issue of Equity
The Company has agreed with a supplier of professional services with an invoice value totalling £21,000, that their fees will be settled through the issue of 70,000 new Guardian Metal ordinary shares of 1.0p each ("Fee Shares") valued at £0.30 per share.
ADMISSION AND TOTAL VOTING RIGHTS
Application will be made for the 70,000 Fee Shares to be admitted to trading on AIM which is expected to occur on or around 21 November 2024 ("Admission"). The Fee Shares will rank pari passu in all respects with the ordinary shares of the Company currently traded on AIM.
Following Admission, the Company's issued share capital will comprise 119,362,385 ordinary shares of 1p each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
Guardian Metal Resources plc Oliver Friesen (CEO) | Tel: +44 (0) 20 7583 8304 |
Cairn Financial Advisers LLP Nominated Adviser Sandy Jamieson/Jo Turner/Louise O'Driscoll | Tel: +44 20 7213 0880 |
Shard Capital Partners LLP (Lead Broker) Damon Heath/Erik Woolgar | Tel: +44 (0) 20 7186 9000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.